ABVC BIOPHARMA, INC.

Develops plant-based drugs and medical devices for CNS, oncology, and ophthalmic disorders.

ABVC | NDAQ

Overview

Corporate Details

ISIN(s):: N/A
LEI:
Country:: United States of America
Address:: 44370 OLD WARM SPRINGS BLVD., 94538 FREMONT
Website:: https://abvcpharma.com/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

ABVC BioPharma, Inc. is a clinical-stage biopharmaceutical company developing drugs and medical devices for unmet medical needs. The company specializes in botanical, plant-based therapies designed for high efficacy and low toxicity. Its development pipeline targets conditions in ophthalmology, oncology, and Central Nervous System (CNS) disorders, including major depressive disorder and adult ADHD. Key products in development include Vitargus®, a biodegradable vitreous replacement, and novel treatments for depression (ABV-1504) and ADHD (ABV-1505). The company in-licenses promising compounds from a global network of research institutions to advance them through clinical trials. Additionally, its subsidiary, BioKey, Inc., provides contract development and manufacturing services for nutritional and pharmaceutical products.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all ABVC BIOPHARMA, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ABVC BIOPHARMA, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for ABVC BIOPHARMA, INC. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Celyad Oncology SA Clinical-stage biotech developing CAR T therapies for solid and blood cancers.	Belgium	CYAD
CENTAUR MEDIA PLC Provides business intelligence, learning, and consultancy for marketing & legal professionals.	United Kingdom	CAU
Century Therapeutics, Inc. Developing iPSC-derived, off-the-shelf cell therapies for cancer & autoimmune diseases.	United States of America	IPSC
Cereno Scientific AB Develops epigenetic therapies for rare cardiovascular and pulmonary diseases.	Sweden	CRNO
CERES INC. Develops online media platforms connecting consumers with advertisers through a rewards system.	Japan	3696
Certara, Inc. Accelerating new medicines with biosimulation software and services for pharma & biotech.	United States of America	CERT
CEVA INC Licensor of DSP, AI, wireless, and sensing IP for low-power, smart edge devices.	United States of America	CEVA
Chabiotech Co.,Ltd. Develops cell/gene therapies and offers CDMO, biobanking, and genomics services for rare diseases.	South Korea	085660
Chai Communication Co., LTD. An Ad-Tech firm providing digital marketing, SEO, social media, and creative ad solutions.	South Korea	351870
CHAMPIONS ONCOLOGY, INC. Oncology CRO accelerating drug development with PDX models and multi-omic data analytics.	United States of America	CSBR